1,6-Naphthyridine-3-carboxylicacid,4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-,(4S)-;(S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylicacid;(S)-4-(4-CYANO-2-METHOXYPHENYL)-5Chemicalbook-ETHOXY-2,8-DIMEChemicalbookTHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLICACI;1,6-Naphthyridine-3-carboxylicacid,4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-,(4S)Chemicalbook-;FINERENONEIMP13/ACIDIMP;FinerenoneImpurity01
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Finerenone Impurity 17 is a synthetic reference standard for the non-steroidal mineralocorticoid receptor antagonist Finerenone. It serves as a critical quality control material in pharmaceutical manufacturing to ensure drug purity and compliance with ICH guidelines. The compound is typically characterized by its specific molecular structure and degradation profile.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used in HPLC method validation to identify and quantify trace impurities in Finerenone bulk drugs.</li>
<li><strong>R&D Support:</strong> Employed during stability studies to monitor degradation pathways and establish shelf-life parameters.</li>
<li><strong>Regulatory Compliance:</strong> Provided for submission dossiers to demonstrate adherence to pharmacopoeial standards regarding impurity thresholds.</li>
</ul>
<h3>Precautions</h3>
<p>This substance is intended for research use only and not for clinical administration. Store under inert atmosphere at -20°C to prevent hydrolysis. Handle with appropriate PPE to avoid skin contact or inhalation of dust particles.</p>